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Abstract
Palliative medicine must prioritize the routine assessment of the quality of clinical care we 
provide. This includes regular assessment, analysis, and reporting of data on quality. Assessment 
of quality informs opportunities for improvement and demonstrates to our peers and ourselves the 
value of our efforts. In fact, continuous messaging of the value of palliative care services is needed 
to sustain our discipline; this requires regularly evaluating the quality of our care. As the 
reimbursement mechanisms for health care in the United States shift from fee-for-service to fee-
for-value models, palliative care will be expected to report robust data on quality of care. We must 
move beyond demonstrating to our constituents (including patients and referrers), “here is what 
we do,” and increase the focus on “this is how well we do it” and “let’s see how we can do it 
better.” It is incumbent on palliative care professionals to lead these efforts. This involves 
developing standardized methods to collect data without adding additional burden, comparing and 
sharing our experiences to promote discipline-wide quality assessment and improvement 
initiatives, and demonstrating our intentions for quality improvement on the clinical frontline.
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The specialty of palliative care has undergone remarkable growth over the past decade.1 The 
reasons for this growth are many, most notably, the simultaneous uptake of palliative 
philosophy into mainstream medical care coupled with the demonstration of the value in 
improving patients and health systems outcomes.2,3 There has been a conscious, discipline-
wide effort to develop and communicate a growing evidence base, ultimately conveying a 
compelling data-driven story that argues for the need for palliative care, characteristics of 
best practice, and demonstrated benefit.4
Just as there is the need to develop and disseminate research-informed evidence on best 
palliative care, there is the need to ensure that the care provided at the clinical frontline 
aligns with expectations of best practice. This alignment meets the expectations on the 
horizon, demanding dramatic shifts in the way care is delivered, evaluated, and reimbursed 
across all medical disciplines. Similarly to other fields, palliative care across all aspects of 
the serious illness trajectory must be prepared to meet an evolving imperative for quality 
assessment, reporting, and monitoring. This requires greater participation by all members of 
the palliative care community in demonstrating high-quality care that respects the art and 
science of our practice. Here we review several critical areas related to quality in palliative 
care in order to understand where we are, outline the roadmap for where we need to go, and 
explore some approaches for getting there.
Improving the Quality of Care Is Intrinsic to Palliative Care
Routine quality assessment as a method to improve patient-centered care is an intrinsic 
component of the spirit of palliative care. Ensuring that all palliative care patients receive 
excellent care has been a priority for the hospice and palliative care movement since its early 
years. When reflecting on the varying quality of care for seriously ill and dying British 
patients in the 1970s, Dame Cicely Saunders was quoted as saying to a colleague, “We can 
only send our patients to (a named institution) when they are becoming unconscious and we 
can reassure the families that they will not realize where they are going.”5 Even during the 
formative years of the palliative care movement, Dame Saunders identified differences 
across institutions in quality of care provided. Parallel to the establishment of a clinical 
service came the recognition that not all services would be equal; quality would have to be 
monitored. Dame Saunders first identified this issue in hospice care; naturally, this attention 
extends to all other palliative care service models as well.
Sadly, poor processes of end-of-life care also have touched those who have been influential 
in the field of quality improvement in health care. Avedis Donabedian, who most people 
identify as the father of the modern health care quality movement, lamented on his own 
personal experience with end-of-life care in an interview with Fitzhugh Mullan.6 Dying of 
advanced prostate cancer, Dr. Donabedian noted several instances of lack of care 
coordination, delays and inefficiencies in care delivery, and a certain detachment between 
his care providers and understanding his personal story. He also remarked about the 
seemingly poor understanding of suffering in those with serious illness, and the continued 
misperceptions regarding the role of opioids, double effect, and providing comfort without 
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hastening death. His experience was representative of standard practice at the time and led 
many health care quality experts to conclude that quality of palliative care in the United 
States must continue to evolve.
The Evolving Landscape of Quality and Value Within Health Care Reform
The way health care is delivered, evaluated, and reimbursed is rapidly changing. In the face 
of shrinking reimbursement and financially unsustainable practices, new models for 
evaluating value of care and matching that value to reimbursement are being developed. 
These have a common theme: transitioning from reimbursement systems that are highly 
dependent upon fee-for-service and undefined accountability, to value-based purchasing and 
accountable care organizations (ACOs) that stress physician and medical group 
responsibility for quality of care and outcomes.
Emerging quality and performance metrics for palliative and supportive care herald evolving 
expectations for routine collection of quality monitoring data (e.g., the National Consensus 
Project Clinical Practice Guidelines for Quality Palliative Care,7 National Quality Forum,8 
Center for Medicare and Medicaid Services [CMS] Conditions of Participation for hospice 
organizations, and CMS Physician Quality Reporting System [PQRS]). To date, the most 
widespread payer expectation is reflected by CMS’s PQRS, a quality measure-based, 
physician reimbursement program. The recent endorsement of quality measures for 
palliative care by the National Quality Forum (Fig. 1) was a key step in establishing PQRS 
for palliative medicine. At its inception, PQRS offered a bonus of up to 2% of physician 
Medicare fees for satisfactory reporting of data on quality. By 2015, the bonus will be 
replaced by a penalty system for incomplete reporting. Moreover, public reporting of the 
results of quality monitoring activities is increasing. For example, CMS plans to go live 
soon with its Physician Compare website, which is a publicly-reported dashboard for 
patients and payers to use to compare quality of care across physicians and practice 
organizations.
Additionally, the program for Advanced Certification for Palliative Care by The Joint 
Commission (TJC) places continued emphasis on continuous quality assessment and 
improvement. As announced by TJC, a key eligibility criterion for Advanced Certification is 
the demonstration of using data capture on the provision of care quality to drive continuous 
performance improvement. Meeting these expectations requires mature, tested processes for 
quality monitoring and improvement efforts that address areas for optimization in timely and 
effective ways.
Most importantly, palliative care needs to foster active quality monitoring to ensure that 
definitions of quality are clinically derived and tested, rather than externally imposed. Major 
medical specialties already recognize the importance of quality in health care delivery. For 
example, since 2007, the American Society of Clinical Oncology (ASCO) has conducted a 
discipline-wide quality assessment program called the Quality Oncology Practice Initiative 
(QOPI).9 Using retrospective chart review and abstraction, any outpatient oncology practice 
with at least one ASCO member can participate in uploading data that will inform semi-
annual reports on conformance to a set of disease-specific, end-of-life care, and supportive/
Kamal et al. Page 3













symptom management metrics. Aggregate analyses are reported back to QOPI participants 
to provide feedback and benchmarks to identify areas of excellence and improvement. 
Frequent data collection cycles have demonstrated value in improving adherence to quality 
measures;10 in some states, oncology organizations have leveraged “QOPI-Certification” for 
preferred relationships with payers and advocacy groups.11 In fact, ASCO has been a leader 
in quality measurement in supportive and palliative care, rapidly evolving the QOPI 
measures to include these domains.
There exists great potential for developing such infrastructure and programs in palliative 
care. Current efforts like the Center to Advance Palliative Care (CAPC) National Palliative 
Care Registry and the Palliative Care Quality Network represent excellent examples of how 
collaborative initiatives can inform a greater understanding of the structure and processes of 
palliative care delivery. Another ongoing initiative from the American Academy of Hospice 
and Palliative Medicine (AAHPM) termed “Measuring What Matters” aims to define a set 
of high-value quality measures for our field. These highlight the significant possibilities in 
our field to stay in step with other clinical disciplines.
Reconciling With the “Art” of Palliative Care
Many may worry that any discussion involving quality in palliative care ultimately means 
transitioning to “cookbook medicine,” where conformance to a standard would be 
prioritized over patient-centered care. Some also may worry that in meeting the same 
pressures of health care reform faced by other disciplines, palliative care may lose its 
narrative in an effort to make care more normative. Reflecting on the historical approaches 
to quality assurance (QA) that many of us were taught, this is a reasonable worry. Previous 
techniques for QA stressed methods to find the defective person (i.e., “the bad apple”) and 
pressure him/her into conforming to care processes in line with all of his/her peers. This 
process looked for problematic clinicians and used financial, punitive, or coercive means to 
bring about behaviors consistent with the majority, largely ignoring important process 
factors for why the “right thing” was so hard to accomplish. Or conversely, why the “wrong 
thing” was so easy to do.
Recent approaches of continuous quality improvement (CQI) take a more iterative approach 
that aims to reduce and eventually eliminate “unexplained clinical variation.” Reducing such 
variation addresses the root of many of health care’s inefficiencies, excess costs, and poor 
outcomes. CQI calls for a cultural shift that relies on clinicians constantly asking 
themselves, “How could this process be better?” and “How can I impact this change?” The 
underpinnings of this approach view each clinician as an informed agent who can identify 
bad processes and implement changes. It views medical errors and inefficiencies as results, 
not of bad people, but of suboptimal processes of care. CQI also recognizes that 
heterogeneity in patient characteristics, values, and clinical settings dictates that prudent 
decision making formulated to reduce unnecessary clinical variation does not mean that 
100% of care may meet a quality measure. A current example of this type of approach 
comes from the American Board of Internal Medicine Foundation’s Choosing Wisely® 
campaign. This campaign, in which the AAHPM recently participated, aims to identify five 
areas of low value services that clinicians and patients should question – but not necessarily 
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eliminate. Sometimes, clinician variance from standard processes meets a patient-centered 
wish or value. Certainly, palliative care practitioners understand the importance of honoring 
some requests to promote quality of life and ease suffering. This focus cannot change on the 
way to standardizing our best practices.
The newer CQI approach also recognizes the need for “balance measures.” These types of 
measures complement usual care process measures by serving as a “check and balance” to 
limit unintended or unwarranted consequences from over-adherence to other measures. For 
example, all palliative care clinicians have cared for a patient who underwent an 
unnecessary health maintenance examination (e.g., screening colonoscopy or Pap smear) in 
the setting of an unrelated, terminal disease. In this case, the usual metric that all patients 
over age 50 undergo colorectal cancer screening is balanced with a measure that 
acknowledges that such screening is not appropriate in a person with a limited life 
expectancy.
Further, there is increased recognition that the patient voice is an important component of 
the health care quality equation. Patient-centered decision making, patient preferences, and 
patient values are now increasingly appreciated when quality is measured and reported. 
Currently, these are measured through patient and family satisfaction with care surveys. In 
the future, a broader portfolio of approaches may assess the delivery of a patient-centered 
process (e.g., “Pain was treated in a manner acceptable to the patient”) rather than a 
clinician-directed process (e.g., “An opioid was given to all patients with moderate/severe 
pain”). Overall, when considering people over processes, clinical relevance over rote 
adherence, and patient values above filling checkboxes, many may find quality improvement 
in health care is transitioning to being much more practical and implementable than a decade 
ago.
Short-Term Priorities – “Getting to Good”
Four key areas will help further high-quality palliative care tailored to individual and 
caregiver needs. Approaches are still in evolution.
Further Define “High-Quality Palliative Care”
Current evidence development focuses on palliative care’s impact on quality of life, 
caregiver satisfaction, and possibly survival. Similarly, it is important to outline what 
structural (e.g., team make-up, team member expertise), process (e.g., how spiritual 
assessments are performed), and outcome (e.g., how is value to a hospital calculated?) 
characteristics yield the highest quality care. In other words: “What is in the palliative care 
syringe?” Clearly not new questions for the field, we are left refining many answers to some 
of the same questions from a decade ago:
Great strides have been made by the National Quality Forum and National Consensus Panel 
on Palliative Care; several consensus documents from CAPC12–15 also strengthen our 
knowledge in these areas. These are complemented by evidence from key studies about the 
components of outpatient palliative care that may improve patient-centered outcomes in 
advanced cancer.16–18 However, the majority of the information describing the 
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characteristics of high-quality palliative care originates from hospital-based consultation 
services. We need to expand exploration of the characteristics of quality palliative care 
service delivery to encompass the diverse and heterogeneous settings in which patients 
require care. For example, quality measures pertinent to outpatient19 and community-based 
palliative care settings20 are needed to complement the hospital-based measures.
We also need to expand our thinking in terms of the relationship between palliative care 
quality and demonstration of value. Recent attention on value in health care has emphasized 
the need for reducing costs while increasing quality, and, in fact, palliative care has matured 
alongside a philosophy of cost avoidance and containment. However, this viewpoint has 
placed several challenges on our field that requires shaping the conversation differently. 
Becoming a service of “loss leaders” has limited the ability of palliative care programs to 
expand personnel and venture into new horizons that have unproven cost avoidance benefits. 
When those outside the field see the value of our services as mainly avoiding costs, we leave 
ourselves unprepared to demonstrate that palliative care improves overall care quality 
through also increasing patient-centered care. Demonstrating that we improve quality of care 
for entire populations, with cost avoidance being a natural downstream benefit – but not the 
only benefit – will further the growth of our services and acceptance of our care philosophy.
Strengthen Current Quality Monitoring Efforts
The discipline of palliative care must update its processes for quality assessment, 
monitoring, reporting, and improvement. This task requires building infrastructure to 
efficiently incorporate data that harnesses the experiences of individuals and organizations 
to lead to generalizable knowledge for the field. This requires careful planning to leverage 
the power of the collective while also respecting the autonomy and independence of each 
organization. In other words, this represents a paradigm shift to reflect the mantra of 
“collecting [data] locally, but affecting [understanding of the quality of care] globally.”
Currently, two uncoordinated retrospective approaches to quality monitoring are used in 
palliative care: singular, program-level efforts and retrospective analysis of registry and 
administrative claims data. Individual organization-level assessments are the most common 
approach, usually consisting of labor-intensive chart review to document program-level 
conformance to chosen metrics. Recent studies have questioned the validity and reliability of 
retrospective chart abstraction;21,22 serious errors in over- and under-estimation of quality 
conformance are demonstrated when abstracted clinical documentation data are repurposed 
for quality monitoring.23 Ideally, clinical documentation would contribute to clinical and 
quality data collection simultaneously. In fact, the lack of value in impacting individual, 
patient-level care becomes the foremost roadblock to clinician acceptance of regular data 
collection on quality.24 In palliative care, we need to aspire to a vision of real-time data 
collection and reporting that has immediate clinical value to providers.
The other approach, using administrative data, remains limited because of concerns of 
comprehensiveness and logistical ability. Large health system and payer claims databases 
often lack the level of clinical data (e.g., cancer stage, coronary vessel name and degree of 
obstruction in coronary artery disease, hemoglobin A1c percentage in diabetes) needed for 
detailed assessment of the adequacy of clinical care delivered or to inform specific quality 
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metrics. Patient-reported outcomes (PROs) and other patient-reported data, which capture 
the patient voice such as symptoms and goals of care, are almost never recorded in 
administrative datasets; yet the patient report is critical for palliative care. And when 
patients cannot report their own distress (e.g., delirium, sedation), caregiver-reported data 
should be considered as an important adjunct to usual clinical data. Combining claims data, 
or with clinical chart abstractions, faces the same validity and reliability issues previously 
mentioned and is cumbersome, logistically difficult, and expensive. The addition of 
electronic health record (HER) data may improve the utility of these datasets for palliative 
care, but this remains to be seen. Although valuable to inform program-level questions or for 
short-term studies, retrospective quality assessment through claims data is inadequate for 
continuous quality monitoring.25
Achieving a system of (rapid) learning quality improvement (Fig. 2), which intelligently 
interprets aggregated clinical and administrative data into usable knowledge, requires 
evolving from the current approach that largely comprises individual, retrospective efforts to 
an approach that is prospective, coordinated, and collaborative. Working this way ensures 
processes are iterative and stay “rapid” as technology and algorithms are integrated with the 
model. This parallels similar rapid learning health care efforts in other areas.26
Empower Providers to Take Ownership of Palliative Care Quality Activities
As outlined by the Institute for Healthcare Improvement (IHI), health care providers must be 
considered as vital partners in the data collection processes for quality monitoring, not 
merely customers of the knowledge gained.24 Partnership occurs at two levels of 
participation: during planning and analysis, and during routine clinical documentation. 
Ensuring data timeliness and validity requires that data on the quality of care be recorded 
simultaneously with clinical data, not post-hoc during retrospective chart review, or ad-hoc 
during temporary quality initiatives. This means that the data elements required to inform 
quality measures need to be clinically relevant, and directly embedded in clinical notes. 
Health information technology (HIT) systems can support the collection of critical data 
points simultaneously with episodes of care. Clinician goals for quality monitoring are 
supported through real-time feedback. Further, HIT-enabled approaches overcome the 
challenge of third-party peer review, which is disliked and mistrusted by physicians and a 
toxic method of change management.
Another way to grow clinician involvement is through building palliative care clinician 
familiarity with terminology, techniques, and processes in quality improvement (Table 1). 
Meeting this need prepares clinicians to effectively communicate with leadership within and 
outside their organizations on the quality, outcomes, and value of their palliative care 
programs. This aids in programmatic growth and sustainability and ensures that the 
palliative care team remains a priority within hospitals and health systems
Understand Current Knowledge Gaps in Palliative Care Quality
It is tempting to assert that palliative care is quality care. A growing body of research 
evidence supports the benefits, or “effectiveness” of specialty palliative care. Also, studies 
demonstrate the cost savings and health care utilization avoidance benefits of palliative care. 
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However, the Institute of Medicine’s definition of quality health care includes four 
additional domains – safety, timeliness, equity, and patient-centeredness – that are not well 
represented in current research.
Data about the safety, timeliness, and equity of the care we provide are critical gaps in our 
evidence base. We presume that palliative care is safe, yet the evidence is immature. Several 
interventions we routinely use (e.g., ketamine as an adjuvant for pain management,27 
discontinuation of cardiac medications in hospice28) may have marginal benefits or 
unintended harmful consequences. Enrollment in hospice and access to consultative 
palliative care in hospitals are frequently delayed,29 highlighting an important gap in the 
timeliness of our services. Palliative care has yet to demonstrate non-disparate, equal care 
across races and populations. Palliative care access varies by states and regions and 
minorities are utilizing these services at lower rates than other populations.30–32 Palliative 
care cannot be considered of the highest quality until these issues are prioritized and 
addressed. And, as research evidence evolves, our quality measures need to evolve 
accordingly in order to ensure implementation of evidence into clinical practice.
The Long-Term Roadmap Moving Forward – “Going from Good to Great”
There remain several steps between the current environment — where quality demonstration 
is sporadic and seen as an adjunct to care delivery — to one where quality monitoring is 
continuously integrated within clinical care delivery and documentation. Further, quality 
monitoring must be coordinated and networked between multiple providers and 
organizations. The roadmap to achieve these lofty goals includes at least six, fundamental 
steps:
1. All palliative care team members (physicians, advance practice providers, nurses, social 
workers, chaplains) should lead the effort to make quality assessment and reporting a 
discipline-wide expectation
Impending changes to how health care is delivered and evaluated requires us to regard 
quality-related activities as crucial to the viability and growth of our organizations and 
discipline. Providers must lead this effort by being informed and engaged participants in the 
process to conduct quality assessments, address areas for improvement, and report successes 
to colleagues, administrators, and payers. Quality-related activities must be efficient and 
useful, not burdensome. Quality champions must be encouraged to report processes that are 
easily implemented. Further, we must provide an adequate stage equal to that of educational 
and research reports in order to share lessons learned and future directions.
2. Develop, standardize, and share highly effective methodologies for quality activities
Quality-related activities must be efficient, impact daily patient care, and integrate into usual 
clinical activities. Historical approaches, such as retrospective chart abstractions and registry 
reviews to evaluate quality are outdated. Prospective data collection, such as in EHRs and 
electronic and billing databases, should be the norm. Without such a transition, the needs of 
“my patient” will never be met at the point that important clinical decisions need to be made 
if information on quality is only available from a de-identified, aggregated, six-month, 
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retrospective cohort. These data work well to audit practices, but perform poorly in guiding 
the care of individual patients.
3. Foster existing, and develop new, collaborations for quality data collection, sharing, and 
analysis
Historically, palliative care has been handicapped by the problem of the “siloed Excel file” 
(Microsoft Office™). Almost every palliative care organization and consultation team has a 
local database to warehouse operations and service data. These files are generally not 
standardized in terms of data elements, are not interoperable in terms of answer choices, nor 
transferable between organizations because of the lack of formal agreements for data 
sharing. Pooling and sharing data are necessary to multiply the effectiveness of lessons 
learned. This requires careful development of interoperable and scalable data systems to 
compare experiences across practices. In doing so, champions, and areas for improvement 
where organizations can assist each other, can be identified.
4. Develop and rigorously test quality measures for palliative care
The National Quality Forum has recently endorsed the first set of palliative care quality 
measures (Fig. 1). This is an important step to incorporate quality measures into private and 
public payer-based reimbursement programs. To keep in step with the increased use of 
quality measures across all aspects of health care, we must look towards the future by 
developing, testing, and implementing the next generation of measures. These new measures 
must be rigorously tested for feasibility in busy clinical environments and validated for 
content, reliability, and ability to inform quality assessment and improvement efforts. Then, 
we can ensure that specific measures are valuable, useful, and doable in all settings where 
palliative care is delivered.
5. Outline a collective agenda for quality-based research
Through its evolving research infrastructure, palliative care sits uniquely poised to be the 
driver of linking high-quality care with improvement in patient, caregiver, and health system 
outcomes. Several questions regarding effective palliative care team structures, value of 
processes outside of symptom management and psychosocial care (e.g., spiritual 
assessments), and outcomes beyond cost containment and quality of life (e.g., depression, 
survival) remain unanswered.
Building the evidence base through research should incorporate both usual and learning 
health care methods. Learning health care approaches leverage the massive amounts of 
clinical, administrative, and billing data produced through usual clinical encounters to gain 
new knowledge. This does not require development of new data collection tools or 
registries; rather, it uses the wealth of information found within current databases to study 
questions related to comparative effectiveness and outcomes. This promotes an iterative 
approach, where small, continuous evolutions in the evidence base result from regular 
analyses of existing data sources. Thus, we acknowledge that the best practices are not yet 
completely understood, but will be adjusted along the way as new wisdom is gained.
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6. Lead from the front and drive the conversation of quality benchmarking, metrics, and 
accountability across all of medicine
Medical disciplines have remained reactive to expectations placed by payers and accreditors 
to define quality palliative care. Positioning instead in a proactive stance will aid the uptake 
of quality efforts within our field. Ultimately, palliative care professionals should define the 
quality of care our patients receive, and demonstrate what it looks like. We should be 
stewards for best quality care across medicine. We should collectively push the boundaries 
from “novel” to “standard,” and from “sometimes” to “always.” There is an important 
imperative to accomplish two tasks simultaneously: get it “right” and make it “routine.” 
Routinely performing an ineffective process does not advance our field any more than 
occasionally performing an effective process. All patients, in all settings, at all times, should 
expect to receive similar, highly effective palliative care that is vetted, tested, benchmarked, 
and re-examined continuously.
Our Collective Imperative
Palliative care is uniquely positioned, as it continues to refine both its mission and expand 
its access, to serve as the model for other disciplines in the arena of quality. We have not 
grown too large to change. We remain flexible and agile to influence dramatic 
improvements in care delivery. This occurs through simultaneously fostering quality 
monitoring programs on individual program levels while developing community and 
academic partnerships to compare, share, and benchmark data. Because we span multiple 
chronic diseases, include team members from various disciplines, and deliver care in diverse 
locations, developing a central quality-related agenda presents a unique challenge. The 
challenge also includes respecting the heterogeneity of our field while also answering the 
demands placed outside of ourselves to report on quality. Just as health care systems are 
embracing the multidisciplinary and comprehensive care plan approach innate to clinical 
palliative care, we should be prepared to use the same intensity and cooperative nature to 
transition the conversation. This transition shifts the messaging within ourselves and to our 
peers from “This is what we do” to “This is how we do it well.”
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Table 1
Key Terms for Understanding Quality in Palliative Care
Term Definition Implications for Palliative Care
Quality Health Care The degree to which health care services for individuals and 
populations increase the likelihood of desired health outcomes 
and are consistent with current professional knowledge.
The emphasis on consistency with current 
knowledge highlights evidence-based 
practice as a hallmark of quality care, not 
only conformance with developed quality 
measures.
Value “Value of Care” as a measure of specified stakeholder’s (such as 
an individual patient’s, consumer organization’s, payer’s, 
provider’s, government’s, or society’s) preference-weighted 
assessment of a particular combination of quality and cost of 
care performance.
Largely, palliative care has defined its value 
to a health care system through its cost 
savings and avoidance; its quality of care 
must now be stressed.
Performance Measurement The mechanism for measuring value. The Institute of Medicine 
recently called for “a coherent, robust, integrated performance 
measurement system that is purposeful, comprehensive, 
efficient, and transparent.
This underscores the needs for systems, that 
have farther scope than individual projects.
Pay for Performance Enhancing or reducing payments through fee schedules, bonuses 
or other incentives based on performance on certain measures of 
quality and value.
This is the result of an evolution past fee-for- 
service models where quantity of care is less 
valued than quality or outcomes of care.
Transparency Refers to providing information about quality or value to 
policymakers, providers and consumers of health care services. 
Patients and their families have the right to the information that 
will help them make informed choices about health care 
services. If relative value information is made available to health 
care purchasers, the expectation is that they will make more 
informed decisions and perhaps reward higher value providers 
with their business.
With a national trend towards publicly-
available reporting, this piece is key for 
palliative care to remain in step with other 
medical disciplines.
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